Novo Nordisk, Eli Lilly Shares Decrease After Roche Reveals Obesity Drug Trial
Shares of pharmaceutical companies Novo Nordisk and Eli Lilly slid after Roche announced results from a promising early-stage trial for its proposed obesity drug.